| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |